Saturday, May 25, 2024

NAFDAC Disprove Glucozil Herbal Medicine for Diabetes Treatment

The National Agency for Food and Drug Administration and Control has refuted claims that it granted approval for the use of “Glucozil,” a local herbal medicine, for the treatment and diabetes and Benign Prostatic Hyperplasia.

NAFDAC said Glucozil was said to have been purportedly developed by the Ambrose Alli University, Ekpoma, Edo State, and that it underwent scientific testing, which certified it safe for both humans and animals.

Reacting to the viral information on Tuesday, the Director-General of NAFDAC, Mojisola Adeyeye, explained that the product was listed by the agency on November 10, 2020, specifically for managing high blood sugar.

She stated, “The agency listed Glucozil capsule on November 10, 2020, for the “MANAGEMENT OF HIGH BLOOD SUGAR” (as captured on the approved label and Listing Certificate issued to the applicant), which was valid till 9th November 2022. Therefore, the herbal medicine certificate has expired.

Read Also: Prioritise Local Drug Manufacturing, Health Insurance stakeholders Task Tinubu

“As specified in the Herbal Medicine & Related Products Labelling Regulations 2021, this listing was subject to the inclusion of the mandatory Disclaimer. “These claims have not been evaluated by NAFDAC” on the product label. This is the regular disclaimer that is used and required for other listed herbal products, which have not undergone Clinical Trials that the Agency deemed satisfactory.”

NAFDAC denies approving Glucozil herbal medicine for diabetes treatment

NAFDAC maintained that claims of the herbal medication being capable of treating, curing, or preventing diabetes, BPH, or detoxification, were never approved by NAFDAC and should be disregarded by the public.

“Treatment, Curative and Preventive Claims for Diabetes, Benign prostatic hyperplasia and detoxification were never approved for Glucozil as claimed in the publication and hence should be disregarded by the public,” she added.

The NAFDAC DG further clarified that AAU was not the manufacturer or applicant for the product, thus, rendering the listing invalid.

She emphasised that the university should have verified the status of the herbal medicine certificate and its approved claims.

“From our records, Ambrose Alli University was neither the manufacturer nor the applicant of the said product for which the listing is no longer valid. The University should have verified the status of the herbal medicine certificate and the approved claim.

“Manufacturing, Distribution or Marketing of this product is not allowed until the renewal application has been submitted and approved by the agency.”

She, however, assured Nigerians that NAFDAC is committed to ensuring public health and safety through stringent regulatory oversight remains steadfast.

“It is crucial to exercise caution when interpreting health-related claims therefore we encourage the public to refer to NAFDAC’s official communications channels for accurate updates and information.”

Related Articles


Please enter your comment!
Please enter your name here

For Advert Placements, Email:

Latest Articles